A rapid and efficient method for generating anti-variable region monoclonal antibodies using type-1 interferons as immune modulators

Human Antibodies

Volumn 15, Issue 3, 2006, Pages 61-69

  Staquet, Kimberly ^a   Fisher, Jamie ^a   Lamb, Roberta ^a   Bannish, Gregory ^a   Duchala, Cynthia ^a   Mbow, M Lamine ^a   Rycyzyn, Michael A ^a   Giles Komar, Jill ^a  

^a CENTOCOR INC   (United States)

Author keywords

Adjuvant; Anti variable region monoclonal antibodies; Antibody secreting cell; B cell proliferative agent; Hybridoma; Interferons

Indexed keywords

CD40 ANTIGEN; EPITOPE; IMMUNOGLOBULIN ANTIBODY; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; INTERFERON; MONOCLONAL ANTIBODY; REAGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DENATURATION; TECHNIQUE; TIME;

EID: 33750254887     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2006-15301     Document Type: Article

References (15)

1. W.A. Findlay, W.C. Smith, J.W. Lee, G.D. Nordblom, I. Das, B.S. DeSilva, M.N. Khan and R.R. Bowsher, Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective, J. Pharm. Biomed. Anal. 21 (2000), 1249-1273.
2. D. Horninger, E. Eirikis, C. Pendley, J. Giles-Komar, H.M. Davis and B.E. Miller, A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFα antibody in human serum, J. Pharm. Biomed Anal. 38 (2005), 703-708.
3. A.N. Theofilopoulos, R. Baccala, B. Beutler and D.H. Kono, Type 1 interferons (alpha/beta) in immunity and autoimmunity, Ann. Rev. Immunol. 23 (2005), 307-336.
4. J. Banchereau, F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C van Kooten, Y.J. Liu, F. Rousset and S. Saeland, The CD40 Antigen and its Ligand, Ann. Rev. Immunol. 12 (1994), 881-926.
5. C.A. Biron, Interferons α and β as immune regulators - a new look, Immunity 14 (2001), 661-664.
6. A. Le Bon and D.F. Tough, Links between innate and adaptive immunity via type I interferon, Curr. Opin. Immunol. 14 (2002), 432-436.
7. S.M. Santini, T. Di Pucchio, C. Lapenta, S. Parlato, M. Logozzi and F. Belardelli, The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity, J. Interferon Cytokine Res. 22 (2002), 1071-1080.
8. P. Marrack, J. Kappler and T. Mitchell, Type I interferons keep activated T cells alive, J. Exp. Med. 189 (1999), 521-530.
9. + T cells in vivo by IL-15, Immunity 8 (1998), 591-599.
10. M.B. Litinskiy, B. Nardelli, D.M. Hilbert, B. He, A. Schaffer, P. Casali and A. Cerutti, DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL, Nat. Immunol. 3 (2002), 822-829.
11. A. Le Bon, G. Schiavoni, G. D'Agostino, I. Gresser, F. Belardi and D.F. Tough, Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo, Immunity 14 (2001), 461-470.
12. Y.J. Liu and J. Banchereau, The paths and molecular controls of peripheral B-cell development, The Immunologist 4 (1996), 55-66.
13. A.C. Lagerkvist, C. Furebring and C.A. Borrebaeck, Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning, Biotechniques 18 (1995), 862-869.
14. W.G. Niedbala and D.I. Stott, A comparison of three methods for production of human hybridomas secreting autoantibodies, Hybridoma 17 (1998), 299-304.
15. P. Bjorck, S. Larsson, M. Andang, L. Ahrlund-Richter and S. Paulie, IL-6 antisense oligonucleotides inhibit IgE production in IL-4 and anti-CD40-stimulated human B-lymphocytes, Immunol Lett. 61 (1998), 1-5.